- Trials with a EudraCT protocol (17)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
17 result(s) found for: Menopur.
Displaying page 1 of 1.
EudraCT Number: 2008-006775-67 | Sponsor Protocol Number: FE 999906 CS08 | Start Date*: 2009-04-29 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, open-label, assessor-blind, parallel groups, multicentre trial compating the efficacy of MENOPUR versus recombinant FSH in controlled ovarian stimulation following a GnRH antagonist p... | |||||||||||||
Medical condition: Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) SE (Completed) ES (Completed) CZ (Completed) PL (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002679-34 | Sponsor Protocol Number: 1-2005 | Start Date*: 2005-11-02 |
Sponsor Name:The Fertility Clinic, Sygehus Viborg (Skive) | ||
Full Title: The effect of LH priming in early follicular phase on the endocrinological function of the ovary and pregnancy rate in GnRh downregulated women stimulated by exogen gonadotophins in IVF-treatment | ||
Medical condition: Infertility | ||
Disease: | ||
Population Age: | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005099-27 | Sponsor Protocol Number: IIBSP-FOS-2014-67 | Start Date*: 2015-05-18 |
Sponsor Name:Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau ? IIB Sant Pau | ||
Full Title: randomized, single blind, prospective clinical study to compare hFSH-HP (Fostipur) and hMG-HP (Menopur) in patients with polycystic ovary ander a FIV/ICSI cicle. | ||
Medical condition: women with polycystic ovary under a cicle of FIV/ICSI. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-021021-13 | Sponsor Protocol Number: 10EU/HMG02 | Start Date*: 2010-11-25 | |||||||||||
Sponsor Name:IBSA, Institut Biochimique S.A. | |||||||||||||
Full Title: Safety and efficacy study comparing a new hMG formulation (hMG-IBSA) to a reference product (Menopur®) in patients undergoing ovarian stimulation for in vitro fertilisation (IVF). | |||||||||||||
Medical condition: Patients, with basal FSH <10 IU/L and E2 <80 pg/ml (~290 pmol/l), undergoing controlled ovarian stimulation for in vitro fertilisation. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) DK (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000993-29 | Sponsor Protocol Number: 04I/HMG10 | Start Date*: 2005-07-19 | |||||||||||
Sponsor Name:IBSA | |||||||||||||
Full Title: A prospective, randomized, investigator-blind, controlled, clinical study of phase III on the clinical efficacy and tolerability of hMG-IBSA IBSA Institut Biochimique sa versus Menopur Ferring ... | |||||||||||||
Medical condition: COH Controlled Ovarian Hyperstimulation in ART Assisted Reproductive Technology /IVF | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001034-18 | Sponsor Protocol Number: NL43131-018-13 | Start Date*: 2013-09-05 | |||||||||||
Sponsor Name:AMC Amsterdam | |||||||||||||
Full Title: Super ovulation in intrauterine insemination: FSH or Clomifene citrate | |||||||||||||
Medical condition: Women diagnosed with unexplained subfertility or mild male factor subfertility with an indication for intra uterine insemination | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005762-28 | Sponsor Protocol Number: 1512-VLC-066-EB | Start Date*: 2016-04-06 |
Sponsor Name:IVI Valencia | ||
Full Title: Analysis of follicular steroid synthesis during controlled ovarian stimulation with recombinant FSH vs HMG in GnRH antagonist cycles | ||
Medical condition: Women undergoing ovarian stimulation for oocyte donation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002979-17 | Sponsor Protocol Number: MANCOR | Start Date*: 2014-01-27 |
Sponsor Name:IVI Sevilla | ||
Full Title: Comparative study between the usage of corifollitropin alfa and daily recombinant FSH in the ovarian stimulation of low responders | ||
Medical condition: Low response to ovarian stimulation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-001743-20 | Sponsor Protocol Number: 1403-MAD-013-AR | Start Date*: 2015-07-30 |
Sponsor Name:IVI Madrid | ||
Full Title: A Multicentre, prospective, randomised clinical trial comparing the cost and efficacy of corifolitropina alfa vs Recombinant FSH and / or HP-hMG | ||
Medical condition: The study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation program | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005331-14 | Sponsor Protocol Number: 1411-MAD-079-CB | Start Date*: 2015-08-19 |
Sponsor Name:IVI Madrid | ||
Full Title: A prospective randomized trial to analyze the effect of the gonadotropin administered during controlled ovarian stimulation on embryo kinetics of development | ||
Medical condition: The study is proposed to analyze the effect of three types of gonadotropin on embryo quality and kinetics of development in women undergoing an assisted reporduction treatment | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-008288-92 | Sponsor Protocol Number: SP-2008-01 | Start Date*: 2010-01-12 |
Sponsor Name:Grupo de Reproducción Asistida HSP/FP | ||
Full Title: Estudio clínico inicial para determinar las ventajas de emplear un preparado de FSH y LH recombinantes en proporción 2:1 frente a la pauta habitual con menotropina (proporción: 1:1) | ||
Medical condition: Estimulación ovárica en mujeres infértiles | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001307-35 | Sponsor Protocol Number: FE999906 CS004 | Start Date*: 2005-12-22 | |||||||||||
Sponsor Name:Ferring Arzneimittel GmbH | |||||||||||||
Full Title: A prospective, open label, randomised, parallel group, comparative pilot study to study the efficacy and safety of highly purified Menotrophin versus recombinant FSH (Follitropin alfa) administered... | |||||||||||||
Medical condition: sub fertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001590-32 | Sponsor Protocol Number: MMC-2016-01 | Start Date*: 2018-04-19 | |||||||||||
Sponsor Name:Manuel Macía Cortiñas | |||||||||||||
Full Title: Comparison of two protocols of controlled ovarian stimulation with highly purified menotropin in low-responder patients according to Bologna criteria treated in Spanish public hospitals. | |||||||||||||
Medical condition: PRIMARY INFERTILITY | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002027-42 | Sponsor Protocol Number: POR-ELONVA | Start Date*: 2013-08-14 |
Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | ||
Full Title: PROSPECTIVE AND RANDOMIZED STUDY FOR ASSESSMENT OF CONTROLLED OVARIAN STIMULATION WITH ALFA Corifollitropin IN PATIENTS WITH OVARIAN RESPONSE EXPECTED OR POOR IN VITRO FERTILIZATION CYCLE. | ||
Medical condition: Women who meet the criteria for infertility Bologna | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-018009-26 | Sponsor Protocol Number: FOLLPRIM | Start Date*: 2010-04-14 |
Sponsor Name:FUNDACION PARA LA INVESTIGACIÓN LA FE | ||
Full Title: PREPARACIÓN DE FOLICULOS ANTRALES, PREVIA FECUNDACION IN VITRO TIPO ICSI, EN PACIENTES CON BAJA RESPUESTA OVÁRICA. ENSAYO CLÍNICO PROSPECTIVO, ALEATORIZADO, CONTROLADO. | ||
Medical condition: Esterilidad femenina subsidiaria a tratamiento de fecundación in vitro. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005420-42 | Sponsor Protocol Number: S55983 | Start Date*: 2014-02-06 | ||||||||||||||||
Sponsor Name:University Hospital Leuven | ||||||||||||||||||
Full Title: Is postoperative IUI better than expectant management in infertile endometriosis patients with good prognosis based on EFI score? | ||||||||||||||||||
Medical condition: (Sub)Fertility in endometriosis after laparoscopic removal of the endometriosos lesions: an RCT comparing intra-uterine insemination with expectant management | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-003412-31 | Sponsor Protocol Number: BROVALE-2012(BC-POF2012) | Start Date*: 2012-10-01 | |||||||||||||||||||||
Sponsor Name:CUB - Hôpital Erasme | |||||||||||||||||||||||
Full Title: Efficiency and Safety of Ovarian Stimulation with Letrozole for fertility preservation in breast cancer patients. | |||||||||||||||||||||||
Medical condition: The aim of this trial is to offer a safe and efficient alternative protocol to preserve fertility by storing oocytes in breast cancer patients before chemotherapy. Letrozole, an inhibitor of aromat... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
